Cite
Ablation of Dihydroceramide Desaturase 1, a Therapeutic Target for the Treatment of Metabolic Diseases, Simultaneously Stimulates Anabolic and Catabolic Signaling.
MLA
Siddique, Monowarul M., et al. “Ablation of Dihydroceramide Desaturase 1, a Therapeutic Target for the Treatment of Metabolic Diseases, Simultaneously Stimulates Anabolic and Catabolic Signaling.” Molecular & Cellular Biology, vol. 33, no. 11, June 2013, pp. 2353–69. EBSCOhost, https://doi.org/10.1128/MCB.00226-13.
APA
Siddique, M. M., Ying Li, Liping Wang, Jianhong Ching, Mal, M., Ilkayeva, O., Ya Jun Wu, Boon Huat Bay, & Summers, S. A. (2013). Ablation of Dihydroceramide Desaturase 1, a Therapeutic Target for the Treatment of Metabolic Diseases, Simultaneously Stimulates Anabolic and Catabolic Signaling. Molecular & Cellular Biology, 33(11), 2353–2369. https://doi.org/10.1128/MCB.00226-13
Chicago
Siddique, Monowarul M., Ying Li, Liping Wang, Jianhong Ching, Mainak Mal, Olga Ilkayeva, Ya Jun Wu, Boon Huat Bay, and Scott A. Summers. 2013. “Ablation of Dihydroceramide Desaturase 1, a Therapeutic Target for the Treatment of Metabolic Diseases, Simultaneously Stimulates Anabolic and Catabolic Signaling.” Molecular & Cellular Biology 33 (11): 2353–69. doi:10.1128/MCB.00226-13.